Literature DB >> 28550642

Post heroin dose tissue distribution of 6-monoacetylmorphine (6-MAM) with MALDI imaging.

Belin G Teklezgi1, Annapurna Pamreddy1, Sooraj Baijnath1, Nirmala D Gopal2, Tricia Naicker1, Hendrik G Kruger1, Thavendran Govender3.   

Abstract

Heroin is an illicit opioid drug which is commonly abused and leads to dependence and addiction. Heroin is considered a pro-drug and is rapidly converted to its major active metabolite 6-monoacetylmorphine (6-MAM) which mediates euphoria and reward through the stimulation of opioid receptors in the brain. The aim of this study was to investigate the distribution and localization of 6-MAM in the healthy Sprague Dawley rat brain following intraperitoneal (i.p) administration of heroin (10 mg/kg), using matrix-assisted laser desorption/ionization mass spectrometric imaging (MALDI-MSI), in combination with quantification via liquid chromatography mass spectrometry (LC-MS/MS). These findings revealed that 6-MAM is present both in plasma and brain tissue with a Tmax of 5 min (2.8 µg/mL) and 15 min (1.1 µg/mL), respectively. MSI analysis of the brain showed high intensities of 6-MAM in the thalamus-hypothalamus and mesocorticolimbic system including areas of the cortex, caudate putamen, and ventral pallidum regions. This finding correlates with the distribution of opioid receptors in the brain, according to literature. In addition, we report a time-dependent distribution in the levels of 6-MAM, from 1 min with the highest intensity of the drug observed at 15 min, with sparse distribution at 45 min before decreasing at 60 min. This is the first study to use MSI as a brain imaging technique to detect a morphine's distribution over time in the brain.

Entities:  

Keywords:  6-Monoacetylmorphine (6-MAM); Brain; Heroin; Liquid chromatography-tandem mass spectrometry (LC–MS/MS); Matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI)

Mesh:

Substances:

Year:  2017        PMID: 28550642     DOI: 10.1007/s10735-017-9726-3

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  34 in total

Review 1.  Addictive illegal drugs: structural neuroimaging.

Authors:  S Geibprasert; M Gallucci; T Krings
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-29       Impact factor: 3.825

2.  Pharmacokinetic modeling of subcutaneous heroin and its metabolites in blood and brain of mice.

Authors:  Fernando Boix; Jannike M Andersen; Jørg Mørland
Journal:  Addict Biol       Date:  2011-04-11       Impact factor: 4.280

3.  Anatomical distribution of mu, delta, and kappa opioid- and nociceptin/orphanin FQ-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in guinea pig brain.

Authors:  L J Sim; S R Childers
Journal:  J Comp Neurol       Date:  1997-10-06       Impact factor: 3.215

4.  Site of opioid action in the human brain: mu and kappa agonists' subjective and cerebral blood flow effects.

Authors:  T E Schlaepfer; E C Strain; B D Greenberg; K L Preston; E Lancaster; G E Bigelow; P E Barta; G D Pearlson
Journal:  Am J Psychiatry       Date:  1998-04       Impact factor: 18.112

5.  Human erythrocyte but not brain acetylcholinesterase hydrolyses heroin to morphine.

Authors:  A Y Salmon; Z Goren; Y Avissar; H Soreq
Journal:  Clin Exp Pharmacol Physiol       Date:  1999-08       Impact factor: 2.557

6.  MALDI MSI and LC-MS/MS: Towards preclinical determination of the neurotoxic potential of fluoroquinolones.

Authors:  Adeola Shobo; Sooraj Baijnath; Dominika Bratkowska; Suhashni Naiker; Anou M Somboro; Linda A Bester; Sanil D Singh; Tricia Naicker; Hendrik G Kruger; Thavendran Govender
Journal:  Drug Test Anal       Date:  2015-09-18       Impact factor: 3.345

Review 7.  Reward processing by the opioid system in the brain.

Authors:  Julie Le Merrer; Jérôme A J Becker; Katia Befort; Brigitte L Kieffer
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

Review 8.  Approaches using molecular imaging technology -- use of PET in clinical microdose studies.

Authors:  Claudia C Wagner; Oliver Langer
Journal:  Adv Drug Deliv Rev       Date:  2010-09-29       Impact factor: 15.470

Review 9.  Imaging the addicted human brain.

Authors:  Joanna S Fowler; Nora D Volkow; Cheryl A Kassed; Linda Chang
Journal:  Sci Pract Perspect       Date:  2007-04

10.  Distribution of opiate alkaloids in brain tissue of experimental animals.

Authors:  Maja Djurendic-Brenesel; Vladimir Pilija; Neda Mimica-Dukic; Branislav Budakov; Stanko Cvjeticanin
Journal:  Interdiscip Toxicol       Date:  2012-12
View more
  4 in total

1.  Investigating time dependent brain distribution of nevirapine via mass spectrometric imaging.

Authors:  Sipho Mdanda; Sphamandla Ntshangase; Sanil D Singh; Tricia Naicker; Hendrik G Kruger; Sooraj Baijnath; Thavendran Govender
Journal:  J Mol Histol       Date:  2019-11-04       Impact factor: 2.611

2.  Balancing sufficiency and impact in reporting standards for mass spectrometry imaging experiments.

Authors:  Ove J R Gustafsson; Lyron J Winderbaum; Mark R Condina; Berin A Boughton; Brett R Hamilton; Eivind A B Undheim; Michael Becker; Peter Hoffmann
Journal:  Gigascience       Date:  2018-10-01       Impact factor: 6.524

3.  6-Monoacetylmorphine-antibody distribution in tissues from heroin-related death cases: An experimental study to investigate the distributive response.

Authors:  Aniello Maiese; Raffaele La Russa; Maria Chiara David; Santina Cantatore; Alice Chiara Manetti; Alessandra De Matteis; Costantino Ciallella; Paola Frati; Vittorio Fineschi
Journal:  J Cell Mol Med       Date:  2022-08-02       Impact factor: 5.295

4.  Mass Spectrometric Imaging of the Brain Demonstrates the Regional Displacement of 6-Monoacetylmorphine by Naloxone.

Authors:  Belin G Teklezgi; Annapurna Pamreddy; Sphamandla Ntshangase; Sipho Mdanda; Sanil D Singh; Nirmala D Gopal; Tricia Naicker; Hendrik G Kruger; Thavendran Govender; Sooraj Baijnath
Journal:  ACS Omega       Date:  2020-05-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.